Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
5,547 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00081796 | Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer | completed | Phase 3 | 438 | SanofiINDUSTRY | 26 | Aug 21, 2008 | clinicaltrials |
| NCT00698880 | Ipsilateral Hepatic Vein Embolization After Portal Vein Embolization | completed | Phase 2 / Phase 3 | 13 | Asan Medical CenterOTHER | 1 | Jun 17, 2008 | clinicaltrials |
| VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates |
| completed |
| Phase 2 |
| 35 |
| Korean Multiple Myeloma Working PartyOTHER |
| 1 |
| May 6, 2008 |
| clinicaltrials |
| NCT00349115 | TCD Followed by autoSCT for Newly Diagnosed MM Patients | unknown | Phase 2 | 43 | Korean Multiple Myeloma Working PartyOTHER | 1 | May 6, 2008 | clinicaltrials |
| NCT00657176 | An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 36 | Korea Otsuka Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 18, 2008 | clinicaltrials |
| NCT00261092 | GEMOX: Oxaliplatin in Pancreatic Cancer | completed | Phase 2 | 48 | SanofiINDUSTRY | 1 | Apr 15, 2008 | clinicaltrials |
| NCT00654342 | Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer | unknown | N/A | 100 | Chung-Ang UniversityOTHER | 1 | Apr 8, 2008 | clinicaltrials |
| NCT00635323 | Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma | completed | Phase 2 | 73 | PfizerINDUSTRY | 4 | Apr 7, 2008 | clinicaltrials |
| NCT00319514 | Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC | completed | Phase 2 | 78 | Gachon University Gil Medical CenterOTHER | 1 | Mar 12, 2008 | clinicaltrials |
| NCT00319800 | Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC | unknown | Phase 2 | 50 | Gachon University Gil Medical CenterOTHER | 1 | Mar 12, 2008 | clinicaltrials |
| NCT00502762 | Topotecan for Irinotecan-Refractory SCLC | unknown | Phase 2 | — | Gachon University Gil Medical CenterOTHER | 1 | Mar 12, 2008 | clinicaltrials |
| NCT00630214 | Prevention of Hypocalcemia in Patients Undergoing Total Thyroidectomy Plus Central Neck Dissection | completed | Phase 2 | 200 | Asan Medical CenterOTHER | 1 | Mar 6, 2008 | clinicaltrials |
| NCT00625352 | Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma | unknown | Phase 2 | 48 | Ulsan University HospitalOTHER | 1 | Feb 28, 2008 | clinicaltrials |
| NCT00563771 | Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome | completed | Phase 4 | 38 | SanofiINDUSTRY | 1 | Jan 28, 2008 | clinicaltrials |
| NCT00591656 | Systemic Consolidation Therapy After Primary Chemoradiation Therapy for Locally Advanced Cervical Cancer | unknown | — | 69 | Seoul National University HospitalOTHER | 1 | Jan 11, 2008 | clinicaltrials |
| NCT00592059 | Systemic Consolidation Therapy After Chemoradiation Therapy Following Operation for High Risk Early Stage Cervical Cancer | unknown | — | 77 | Seoul National University HospitalOTHER | 1 | Jan 11, 2008 | clinicaltrials |
| NCT00580359 | S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer | unknown | Phase 2 | 96 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 8, 2008 | clinicaltrials |
| NCT00515190 | Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma | unknown | Phase 2 | 198 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00587145 | Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer | unknown | Phase 2 | 44 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00561301 | Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma | unknown | Phase 2 | 43 | Cooperative Study Group A for HematologyNETWORK | 1 | Nov 20, 2007 | clinicaltrials |
| NCT00436423 | A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer | completed | Phase 2 | 38 | Korea University Anam HospitalOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00551486 | Pyrosequencing of the BRAFV600E Mutation | completed | — | 101 | Chungnam National UniversityOTHER | 1 | Oct 31, 2007 | clinicaltrials |
| NCT00549952 | Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients | unknown | — | — | Korea Otsuka Pharmaceutical Co., Ltd.INDUSTRY | 1 | Oct 26, 2007 | clinicaltrials |
| NCT00549276 | Randomized Comparison of Curved Cutter Stapler and Linear Stapler | completed | — | — | Samsung Medical CenterOTHER | 1 | Oct 25, 2007 | clinicaltrials |
| NCT00539630 | TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN | completed | Phase 3 | 86 | SanofiINDUSTRY | 1 | Oct 4, 2007 | clinicaltrials |
| NCT00539669 | TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian | completed | Phase 2 | 47 | SanofiINDUSTRY | 1 | Oct 4, 2007 | clinicaltrials |
| NCT00529880 | Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML | unknown | Phase 2 | 19 | Cooperative Study Group A for HematologyNETWORK | 1 | Sep 27, 2007 | clinicaltrials |
| NCT00516230 | Establishing Effective Screening Methods for Diagnosing Hereditary Nonpolypoisis Colorectal Cancer | unknown | — | 200 | Samsung Medical CenterOTHER | 1 | Aug 15, 2007 | clinicaltrials |
| NCT00509964 | Second-Line Irinotecan vs. ILF for AGC | unknown | Phase 2 | 50 | Gachon University Gil Medical CenterOTHER | 1 | Aug 1, 2007 | clinicaltrials |
| NCT00510107 | Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC | unknown | Phase 2 | 90 | Gachon University Gil Medical CenterOTHER | 1 | Aug 1, 2007 | clinicaltrials |
| NCT00506168 | Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer | terminated | Phase 2 | 37 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00506207 | A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy(TIROX) | unknown | Phase 1 | 23 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00506571 | Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer(TIROX2) | unknown | Phase 2 | 42 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00506623 | Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer | unknown | Phase 2 | 48 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00506844 | Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer(ERBIRIX) | unknown | Phase 2 | 40 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00507143 | Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of Irinotecan | unknown | N/A | 100 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00490399 | Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas | completed | Phase 2 | 39 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 22, 2007 | clinicaltrials |
| NCT00167999 | Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units | completed | — | 200 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Mar 15, 2007 | clinicaltrials |
| NCT00320294 | ILF With/Without Cisplatin for Advanced Gastric Cancer | unknown | Phase 2 | 86 | Gachon University Gil Medical CenterOTHER | 1 | Mar 12, 2007 | clinicaltrials |
| NCT00425022 | VATS Lobectomy for Clinical Stage IB or II Lung Cancer | unknown | Phase 2 | 40 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 30, 2007 | clinicaltrials |
| NCT00190801 | Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00190840 | A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 186 | Eli Lilly and CompanyINDUSTRY | 8 | Jan 26, 2007 | clinicaltrials |
| NCT00329498 | L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes | suspended | Phase 2 | 25 | Samsung Medical CenterOTHER | 1 | Oct 26, 2006 | clinicaltrials |
| NCT00378755 | Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM | unknown | Phase 2 | 62 | Korean Multiple Myeloma Working PartyOTHER | 1 | Sep 22, 2006 | clinicaltrials |
| NCT00373620 | A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients | unknown | Phase 2 | 50 | Korean Gynecologic Oncology GroupOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00319865 | PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma | unknown | Phase 2 | 47 | Korean Multiple Myeloma Working PartyOTHER | 1 | Apr 27, 2006 | clinicaltrials |
| NCT00265694 | Random Trial for Elderly Patients With NSCLC | unknown | Phase 3 | — | Inje UniversityOTHER | 1 | Dec 15, 2005 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials